Warts Clinical Trial
Official title:
Prospective, Single-blinded, Randomized Trial to Evaluate the Efficacy of a Cryogenic Medical Device in Treatment of Common and Plantar Warts Versus a Comparator Product.
The present study was set-up to evaluate clinical efficacy of Pixie CO2 versus a comparator product (Wortie®) for the treatment of common and plantar warts.
The use of cryotherapy has been long known to be effective against warts. The indications for Pixie CO2 are in line with the indications presented in the collected literature data, as well as with the indications of similar devices. The benefits of the use of cryotherapy for warts is clearly evidenced. The treatment period is short (up to 3 treatments with a 14 day interval, compared to daily application of keratinolytics or fluorouracil, over a period of weeks). The cryotherapy application through a conic applicator is much more precise than with most chemical substances. Chemical substance application is leading to more side effects of the surrounding skin (typical for chemical treatment are pain, blistering, ulceration and contact dermatitis). The Instructions for Use were developed in line with these data and are therefore covering all hazards known up to the date of this report. Based on these data the product received its CE-mark approval. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01757392 -
Candin Safety & Efficacy Study for the Treatment of Warts
|
Phase 2 | |
| Completed |
NCT00973856 -
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
|
N/A | |
| Completed |
NCT02902822 -
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
|
N/A | |
| Withdrawn |
NCT00546611 -
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
|
Phase 1 | |
| Completed |
NCT00117871 -
Study With a Topical Gel to Treat Common Warts in Adults
|
Phase 2 | |
| Completed |
NCT04278573 -
Intralesional Vitamin D Injection for Treatment of Common Warts
|
Phase 2 | |
| Completed |
NCT02231879 -
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05617950 -
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
|
N/A | |
| Not yet recruiting |
NCT05616078 -
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
|
N/A | |
| Recruiting |
NCT01712295 -
17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts
|
Phase 4 | |
| Active, not recruiting |
NCT00254280 -
Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial
|
N/A | |
| Completed |
NCT04781244 -
Cost-effectiveness of EndWarts® FREEZE - an Alternative Home Cryotherapy Device for Wart Treatment
|
N/A | |
| Completed |
NCT01101750 -
Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
|
Phase 4 | |
| Completed |
NCT03487549 -
Cantharidin and Occlusion in Verruca Epithelium
|
Phase 2 | |
| Recruiting |
NCT05625633 -
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
|
Phase 2/Phase 3 | |
| Completed |
NCT02393417 -
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
|
Phase 2 | |
| Completed |
NCT01808443 -
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
|
N/A | |
| Completed |
NCT00116662 -
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
|
Phase 2 | |
| Completed |
NCT00116675 -
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
|
Phase 2 | |
| Completed |
NCT00114920 -
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
|
Phase 2 |